Showing results (161-170 of 287) with videos related to
Sort By:
Pageof 29
Deutsche Medizinische Wochenschrift (1946)|November 19, 2005
[Fever of unknown origin in the 21st century: infectious diseases]T Schneider, C Loddenkemper, M Rudwaleit, et al.Chemotherapy|January 1, 1984
Pharmacokinetics of cefotaxime and desacetyl-cefotaxime in cirrhosis of the liverG Höffken, H Lode, P Koeppe, et al.Clinical Therapeutics|January 1, 1980
Comparative pharmacokinetics of cefoperazone and cefotaximeH Lode, B Kemmerich, P Koeppe, et al.Antimicrobial Agents and Chemotherapy|October 1, 1987
Prospective randomized controlled study of ciprofloxacin versus imipenem-cilastatin in severe clinical infectionsH Lode, R Wiley, G Höffken, et al.Deutsche Medizinische Wochenschrift (1946)|July 4, 2006
[Pneumocystis jiroveci pneumonia in immunocompromised patients without AIDS -- a case series]T Blum, A Roth, H Mauch, et al.Chemotherapy|January 1, 1985
Comparative pharmacokinetics of ceftriaxone after subcutaneous and intravenous administrationK Borner, H Lode, B Hampel, et al.Thorax|October 1, 1996
An analysis of decisions by European general practitioners to admit to hospital patients with lower respiratory tract infections. The European Study Group of Community Acquired Pneumonia (ESOCAP) of the European Respiratory SocietyT Schaberg, G Gialdroni-Grassi, G Huchon, et al.European Journal of Clinical Microbiology|April 1, 1983
Pharmacokinetics of multiple doses of ceftizoxime and their influence on fecal floraH Lode, H Warns, B Kemmerich, et al.The Journal of Antimicrobial Chemotherapy|May 1, 1983
Serum bactericidal activity and kinetics of azlocillin and moxalactam after single and combined administrationH Lode, V Madey, G Dzwillo, et al.Therapeutic Drug Monitoring|June 1, 1987
Therapeutic aminoglycoside monitoring in renal failure patientsF Keller, K Borner, A Schwarz, et al.Pageof 29